{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:49Z","timestamp":1789778989806,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13071-017-2018-7","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T10:54:10Z","timestamp":1488365650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Controlled release of artemisone for the treatment of experimental cerebral malaria"],"prefix":"10.1186","volume":"10","author":[{"given":"Jacob","family":"Golenser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed","family":"Nasereddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vakruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"issue":"5","key":"2018_CR1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ajpath.2012.08.010","volume":"181","author":"HJ Shikani","year":"2012","unstructured":"Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux MS. Cerebral malaria we have come a long-way. Am J Pathol. 2012;181(5):1484\u201392.","journal-title":"Am J Pathol"},{"key":"2018_CR2","unstructured":"Hodgson SH, Angus BJ. Malaria: fluid therapy in severe disease. BMJ Clin Evid. 2016."},{"issue":"6","key":"2018_CR3","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.4049\/jimmunol.1000944","volume":"185","author":"FH Amante","year":"2010","unstructured":"Amante FH, Haque A, Stanley AC, Rivera FD, Randall LM, Wilson YA, et al. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol. 2010;185(6):3632\u201342.","journal-title":"J Immunol"},{"issue":"5","key":"2018_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","volume":"36","author":"NH Hunt","year":"2006","unstructured":"Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol. 2006;36(5):569\u201382.","journal-title":"Int J Parasitol"},{"key":"2018_CR5","doi-asserted-by":"crossref","unstructured":"Almelli T, Nuel G, Bischoff E, Aubouy A, Elati M, Wang CW, et al. Differences in gene transcriptomic pattern of Plasmodium falciparum in children with cerebral malaria and asymptomatic carriers. PLoS One. 2014;9(12):e114401.","DOI":"10.1371\/journal.pone.0114401"},{"issue":"8","key":"2018_CR6","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","volume":"73","author":"CJ Clark","year":"2005","unstructured":"Clark CJ, Mackay GM, Smythe GA, Bustamante S, Stone TW, Phillips RS. Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun. 2005;73(8):5249\u201351.","journal-title":"Infect Immun"},{"issue":"11","key":"2018_CR7","doi-asserted-by":"crossref","first-page":"e1500911","DOI":"10.1126\/sciadv.1500911","volume":"1","author":"MJ Hackett","year":"2015","unstructured":"Hackett MJ, Aitken JB, El-Assaad F, McQuillan JA, Carter EA, Ball HJ, et al. Mechanisms of murine cerebral malaria: multimodal imaging of altered cerebral metabolism and protein oxidation at hemorrhage sites. Sci Adv. 2015;1(11):e1500911.","journal-title":"Sci Adv"},{"issue":"10","key":"2018_CR8","first-page":"1179","volume":"64","author":"ASF Sheikh","year":"2014","unstructured":"Sheikh ASF, Sheikh SA, Mohamed MA. Changes in brain metabolites in experimental cerebral malaria infection with Plasmodium berghei ANKA: a literature review. J Pak Med Assoc. 2014;64(10):1179\u201385.","journal-title":"J Pak Med Assoc"},{"issue":"8432","key":"2018_CR9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(85)91445-X","volume":"325","author":"NJ White","year":"1985","unstructured":"White NJ, Warrell DA, Looareesuwan S, Chanthavanich P, Phillips RE, Pongpaew P. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet. 1985;325(8432):776\u20138.","journal-title":"Lancet"},{"issue":"13","key":"2018_CR10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/anie.200503071","volume":"45","author":"RK Haynes","year":"2006","unstructured":"Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, Chan HW, et al. Artemisone - a highly active antimalarial drug of the artemisinin class. Angew Chem Int Ed. 2006;45(13):2082\u20138.","journal-title":"Angew Chem Int Ed"},{"issue":"9","key":"2018_CR11","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.01585-07","volume":"52","author":"J Nagelschmitz","year":"2008","unstructured":"Nagelschmitz J, Voith B, Wensing G, Roemer A, Fugmann B, Haynes RK, et al. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob Agents Chemother. 2008;52(9):3085\u201391.","journal-title":"Antimicrob Agents Chemother"},{"issue":"31","key":"2018_CR12","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.2174\/0929867322666150729115752","volume":"22","author":"R Harmse","year":"2015","unstructured":"Harmse R, Wong HN, Smit F, Haynes RK, N\u2019Da DD. The case for development of 11-Aza-artemisinins for malaria. Curr Med Chem. 2015;22(31):3607\u201330.","journal-title":"Curr Med Chem"},{"issue":"2","key":"2018_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/bdrb.20192","volume":"86","author":"G Schmuck","year":"2009","unstructured":"Schmuck G, Klaus AM, Krotlinger F, Langewische FW. Developmental and reproductive toxicity studies on artemisone. Birth Defects Res B Dev Reprod Toxicol. 2009;86(2):131\u201343.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"2018_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","volume":"9","author":"JH Waknine-Grinberg","year":"2010","unstructured":"Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillan JA, Chan HW, Chan WC, et al. Artemisone effective against murine cerebral malaria. Malar J. 2010;9:227.","journal-title":"Malar J"},{"issue":"8","key":"2018_CR15","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/AAC.01553-13","volume":"58","author":"WA Guiguemde","year":"2014","unstructured":"Guiguemde WA, Hunt NH, Guo JT, Marciano A, Haynes RK, Clark J, et al. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses. Antimicrob Agents Chemother. 2014;58(8):4745\u201354.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"2018_CR16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","volume":"668","author":"L Shakir","year":"2011","unstructured":"Shakir L, Hussain M, Javeed A, Ashraf M, Riaz A. Artemisinins and immune system. Eur J Pharmacol. 2011;668(1\u20132):6\u201314.","journal-title":"Eur J Pharmacol"},{"issue":"8416","key":"2018_CR17","first-page":"1360","volume":"2","author":"GQ Li","year":"1984","unstructured":"Li GQ, Guo XB, Arnold K, Jian HX, Fu LC. Randomized comparative-study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum-malaria. Lancet. 1984;2(8416):1360\u20131.","journal-title":"Lancet"},{"issue":"5","key":"2018_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/QCO.0000000000000199","volume":"28","author":"RM Fairhurst","year":"2015","unstructured":"Fairhurst RM. Understanding artemisinin-resistant malaria: what a difference a year makes. Curr Opin Infect Dis. 2015;28(5):417\u201325.","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"2018_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. Engl J Med. 2014;371(5):411\u201323.","journal-title":"Engl J Med"},{"issue":"5","key":"2018_CR20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/ci700452r","volume":"48","author":"ML Radhakrishnan","year":"2008","unstructured":"Radhakrishnan ML, Tidor B. Optimal drug cocktail design: methods for targeting molecular ensembles and insights from theoretical model systems. J Chem Inf Model. 2008;48(5):1055\u201373.","journal-title":"J Chem Inf Model"},{"issue":"9","key":"2018_CR21","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1128\/IAI.68.9.5364-5376.2000","volume":"68","author":"J Hearn","year":"2000","unstructured":"Hearn J, Rayment N, Landon DN, Katz DR, de Souza JB. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun. 2000;68(9):5364\u201376.","journal-title":"Infect Immun"},{"issue":"6","key":"2018_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pt.2010.03.006","volume":"26","author":"NH Hunt","year":"2010","unstructured":"Hunt NH, Grau GE, Engwerda C, Barnum SR, van der Heyde H, Hansen DS, et al. Murine cerebral malaria: the whole story. Trends Parasitol. 2010;26(6):272\u20134.","journal-title":"Trends Parasitol"},{"issue":"2","key":"2018_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2613.2008.00622.x","volume":"90","author":"YC Martins","year":"2009","unstructured":"Martins YC, Smith MJ, Pelajo-Machado M, Werneck GL, Lenzi HL, Daniel-Ribeiro CT, Carvalho LJD. Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. Int J Exp Pathol. 2009;90(2):119\u201330.","journal-title":"Int J Exp Pathol"},{"key":"2018_CR24","doi-asserted-by":"crossref","unstructured":"Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, et al. Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS One. 2013;8(8):e72722.","DOI":"10.1371\/journal.pone.0072722"},{"issue":"17","key":"2018_CR25","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1021\/ma401044s","volume":"46","author":"K Bubel","year":"2013","unstructured":"Bubel K, Zhang Y, Assem Y, Agarwal S, Greiner A. Tenside-free biodegradable polymer nanofiber nonwovens by \u201cgreen electrospinning\u201d. Macromolecules. 2013;46(17):7034\u201342.","journal-title":"Macromolecules"},{"issue":"12","key":"2018_CR26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mame.201400116","volume":"299","author":"K Bubel","year":"2014","unstructured":"Bubel K, Grunenberg D, Vasilyev G, Zussman E, Agarwal S, Greiner A. Solvent-free aqueous dispersions of block copolyesters for electrospinning of biodegradable nonwoven mats for biomedical applications. Macromol Mater Eng. 2014;299(12):1445\u201354.","journal-title":"Macromol Mater Eng"},{"issue":"5","key":"2018_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijpara.2006.02.009","volume":"36","author":"J Golenser","year":"2006","unstructured":"Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH. Conventional and experimental treatment of cerebral malaria. Int J Parasitol. 2006;36(5):583\u201393.","journal-title":"Int J Parasitol"},{"issue":"2","key":"2018_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exppara.2010.01.005","volume":"125","author":"JH Waknine-Grinberg","year":"2010","unstructured":"Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J. Modulation of cerebral malaria by fasudil and other immune-modifying compounds. Exp Parasitol. 2010;125(2):141\u20136.","journal-title":"Exp Parasitol"},{"key":"2018_CR29","unstructured":"World Health Organisation: Guidelines for the treatment of malaria. Third edition. Geneva: World Health Organisation; 2015. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en . Accessed 9 Feb 2017."},{"issue":"5","key":"2018_CR30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455\u201367.","journal-title":"N Engl J Med"},{"issue":"4","key":"2018_CR31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8(4):272\u201380.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2018_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","volume":"40","author":"T Efferth","year":"2010","unstructured":"Efferth T, Kaina B. Toxicity of the antimalarial artemisinin and its dervatives. Crit Rev Toxicol. 2010;40(5):405\u201321.","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"2018_CR33","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1002\/jps.21685","volume":"98","author":"S Lapenna","year":"2009","unstructured":"Lapenna S, Bilia AR, Morris GA, Nilsson M. Novel artemisinin and curcumin micellar formulations: drug solubility studies by NMR spectroscopy. J Pharm Sci. 2009;98(10):3666\u201375.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2018_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2013.09.027","volume":"457","author":"Y Shahzad","year":"2013","unstructured":"Shahzad Y, Sohail S, Arshad MS, Hussain T, Shah SNH. Development of solid dispersions of artemisinin for transdermal delivery. Int J Pharm. 2013;457(1):197\u2013205.","journal-title":"Int J Pharm"},{"issue":"3","key":"2018_CR35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nano.2008.12.005","volume":"5","author":"Y Chen","year":"2009","unstructured":"Chen Y, Lin X, Park H, Greever R. Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomed Nanotechnol Biol Med. 2009;5(3):316\u201322.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"4","key":"2018_CR36","first-page":"67","volume":"4","author":"E Asgharkhani","year":"2014","unstructured":"Asgharkhani E, Najmafshar A, Chiani M. Artemisinin (ART) drug delivery using mixed non-ionic surfactants and evaluation of their efficiency in different cancer cell lines. Int J Drug Deliv Technol. 2014;4(4):67\u201371.","journal-title":"Int J Drug Deliv Technol"},{"issue":"1\u20132","key":"2018_CR37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2014.03.036","volume":"466","author":"P Dwivedi","year":"2014","unstructured":"Dwivedi P, Khatik R, Khandelwal K, Taneja I, Raju KSR, Wahajuddin, et al. Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats. Int J Pharm. 2014;466(1\u20132):321\u20137.","journal-title":"Int J Pharm"},{"issue":"12","key":"2018_CR38","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3109\/03639045.2012.658812","volume":"38","author":"R Chadha","year":"2012","unstructured":"Chadha R, Gupta S, Pathak N. Artesunate-loaded chitosan\/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm. 2012;38(12):1538\u201346.","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"2018_CR39","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","volume":"11","author":"A Dwivedi","year":"2015","unstructured":"Dwivedi A, Mazumder A, du Plessis L, du Preez JL, Haynes RK, du Plessis J. In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells. Nanomed Nanotechnol Biol Med. 2015;11(8):2041\u201350.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"6","key":"2018_CR40","doi-asserted-by":"crossref","first-page":"e1000963","DOI":"10.1371\/journal.ppat.1000963","volume":"6","author":"PA Reis","year":"2010","unstructured":"Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, et al. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 2010;6(6):e1000963.","journal-title":"PLoS Pathog"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-017-2018-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:11:30Z","timestamp":1568873490000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-017-2018-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2018"],"URL":"https:\/\/doi.org\/10.1186\/s13071-017-2018-7","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"article-number":"117"}}